Influx Health.

Aarth AIF Growth Fund sold 82,200 shares of Influx Healthtech, reducing its stake from 1.40% to 1.04%.

A healthcare-focused contract manufacturing company incorporated in September 2020, Influx Healthtech specializes in producing pharmaceutical products for partner companies across India. The firm operates in the contract manufacturing sector, providing comprehensive end-to-end production capabilities and quality assurance services to pharmaceutical clients. Its business model centers on offering reliable, scalable manufacturing services to established pharmaceutical brands seeking outsourced production capacity and operational efficiency.

Jaipur-based fund managed by Adheesh Kabra and Rishi Agarwal. Runs a bottom-up, research-driven strategy targeting high-growth listed equities and SME-segment companies with strong cash flows and scalable models. Active anchor investor in SME IPOs. Holds 47 disclosed positions as of Q1 2026.